Clinical Study Results
What adverse reactions happened during this study?
The most common adverse reaction was headache.
The table below shows the most common adverse reactions that happened in 5 or
more participants during the study. There were other adverse reactions, but these
happened in fewer participants. The table does not show the adverse reactions
that happened in each group. Because there was a small number of participants in
each group, leaving this information out helps protect their identities.
Most common adverse reactions during the study
Adverse reaction Total (out of 40 participants)
Headache 25.0% (10)
Decreased appetite 17.5% (7)
Infusion site reaction 17.5% (7)
Tiredness 15.0% (6)
Nausea 15.0% (6)
Vomiting 15.0% (6)
Diarrhea 12.5% (5)
How has this study helped patients and
researchers?
This study helped researchers learn more about the safety of MEDI1873 in
participants with advanced solid tumors.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with MEDI1873 are not planned.
9